Heron Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Heron Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Heron Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Heron Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.7k | 2.1k | 0.80 |
| 2023-06-30 | $167k | 111k | 1.51 |
| 2023-03-31 | $167k | 111k | 1.51 |
| 2022-12-31 | $277k | 111k | 2.50 |
| 2022-09-30 | $467k | 111k | 4.22 |
| 2022-06-30 | $309k | 111k | 2.79 |
| 2022-03-31 | $634k | 111k | 5.72 |
| 2021-12-31 | $1.0M | 111k | 9.13 |
| 2021-09-30 | $1.0M | 98k | 10.69 |
| 2021-06-30 | $1.6M | 103k | 15.52 |
| 2021-03-31 | $1.6M | 99k | 16.21 |
| 2020-12-31 | $1.4M | 94k | 14.82 |
| 2020-09-30 | $1.4M | 94k | 14.82 |
| 2020-06-30 | $1.3M | 90k | 14.71 |
| 2020-03-31 | $1.1M | 91k | 11.74 |
| 2019-12-31 | $2.1M | 91k | 23.50 |
| 2019-09-30 | $1.6M | 89k | 18.50 |
| 2019-06-30 | $1.2M | 66k | 18.59 |
| 2019-03-31 | $1.4M | 58k | 24.44 |
| 2018-12-31 | $1.2M | 48k | 25.94 |
| 2018-09-30 | $1.3M | 40k | 31.65 |
| 2018-06-30 | $1.3M | 34k | 38.85 |
| 2018-03-31 | $720k | 26k | 27.60 |
| 2017-12-31 | $230k | 13k | 18.10 |
| 2016-09-30 | $262k | 15k | 17.24 |
| 2016-06-30 | $274k | 15k | 18.03 |
| 2016-03-31 | $289k | 15k | 19.01 |
| 2015-12-31 | $406k | 15k | 26.71 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas